IBT

International Biotechnology Trust Portfolio holdings

AUM $297M
This Quarter Return
+14.86%
1 Year Return
+17.25%
3 Year Return
+11.14%
5 Year Return
+79.35%
10 Year Return
AUM
$366M
AUM Growth
+$366M
Cap. Flow
+$31.2M
Cap. Flow %
8.51%
Top 10 Hldgs %
57.01%
Holding
57
New
4
Increased
13
Reduced
4
Closed
5
Name Market Value Portfolio Weight Shares or Principal Shares
Change %
Capital Flow
HZNP
1
DELISTED
Horizon Therapeutics Public Limited Company Ordinary Shares
HZNP
$32.5M 8.87% 444,000 +55,000 +14% +$4.02M
ACAD icon
2
Acadia Pharmaceuticals
ACAD
$4.38B
$26M 7.1% 486,000
VRTX icon
3
Vertex Pharmaceuticals
VRTX
$100B
$23M 6.28% 97,322 +32,500 +50% +$7.67M
BMRN icon
4
BioMarin Pharmaceuticals
BMRN
$11.2B
$21.7M 5.92% 247,584
PTCT icon
5
PTC Therapeutics
PTCT
$3.92B
$20.3M 5.55% 333,000 +34,000 +11% +$2.08M
GILD icon
6
Gilead Sciences
GILD
$140B
$20.3M 5.54% 348,284 +27,000 +8% +$1.57M
BHVN
7
DELISTED
Biohaven Pharmaceutical Holding Company Ltd.
BHVN
$17.2M 4.69% 200,400 +63,000 +46% +$5.4M
AMGN icon
8
Amgen
AMGN
$155B
$16.5M 4.52% 72,000 +28,000 +64% +$6.44M
CCXI
9
DELISTED
ChemoCentryx, Inc.
CCXI
$15.8M 4.31% 255,600 +232,000 +983% +$14.3M
ALXN
10
DELISTED
Alexion Pharmaceuticals Inc
ALXN
$15.5M 4.23% 99,241 +24,000 +32% +$3.75M
MRTX
11
DELISTED
Mirati Therapeutics, Inc. Common Stock
MRTX
$14.8M 4.04% 67,400 +40,500 +151% +$8.9M
TPTX
12
DELISTED
Turning Point Therapeutics, Inc. Common Stock
TPTX
$13.8M 3.77% 113,541 +78,541 +224% +$9.56M
HALO icon
13
Halozyme
HALO
$8.56B
$13.1M 3.59% 307,633
SGEN
14
DELISTED
Seagen Inc. Common Stock
SGEN
$11.5M 3.13% 65,500
EXEL icon
15
Exelixis
EXEL
$10.1B
$10.6M 2.89% 526,534
XLRN
16
DELISTED
Acceleron Pharma Inc.
XLRN
$9.06M 2.48% 71,000
BIIB icon
17
Biogen
BIIB
$19.4B
$8.02M 2.19% 32,800 -10,800 -25% -$2.64M
INCY icon
18
Incyte
INCY
$16.5B
$6.78M 1.85% 78,000
REGN icon
19
Regeneron Pharmaceuticals
REGN
$61.5B
$5.55M 1.52% 11,500
SRPT icon
20
Sarepta Therapeutics
SRPT
$1.78B
$5.36M 1.47% 31,500
ALNY icon
21
Alnylam Pharmaceuticals
ALNY
$58.5B
$4.72M 1.29% 36,300
IONS icon
22
Ionis Pharmaceuticals
IONS
$6.79B
$4.4M 1.2% 77,781 +38,000 +96% +$2.15M
KALV icon
23
KalVista Pharmaceuticals
KALV
$678M
$3.37M 0.92% 177,433
CRSP icon
24
CRISPR Therapeutics
CRSP
$4.71B
$3.37M 0.92% 22,000
PTGX icon
25
Protagonist Therapeutics
PTGX
$3.67B
$3.06M 0.84% 152,000